Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Tite Minga Mikobi"'
Autor:
Tite Minga Mikobi, Nelly Ciombo Kamuanya, Emmanuelle Ketsia Bokashanga Mikobi, Thérèse Ilunga Kalela, Pierre Zalagile Akilimali, Prosper Tshilobo Lukusa
Publikováno v:
eJHaem, Vol 4, Iss 4, Pp 977-983 (2023)
Abstract Pregnancy is accompanied by hormonal changes. These relate mainly to progesterone and placenate growth factor. Hemodynamic changes are also observed. in a sickle cell pregnant woman, all these changes have a direct effect on hypoxia. This is
Externí odkaz:
https://doaj.org/article/816ec4bac0f6410dab214ec3d08eddb6
Autor:
Paul Lumbala Kabuyi, Gloire Mbayabo, Mamy Ngole, Aimé Lumaka Zola, Valerie Race, Gert Matthijs, Chris Van Geet, Prosper Lukusa Tshilobo, Koenraad Devriendt, Tite Minga Mikobi
Publikováno v:
eJHaem, Vol 4, Iss 3, Pp 595-601 (2023)
Abstract Background: Despite a high incidence of sickle cell anemia, hydroxyurea (HU) treatment is rarely used in the DR Congo. This study aims to assess the efficacy of HU, the incidence of side effects that may limit its use in adults and to determ
Externí odkaz:
https://doaj.org/article/dab20ddfd3a84212b5cada2b70d7092d
Autor:
Gloire Mbayabo, Mamy Ngole, Paul Kabuyi Lumbala, Aimé Lumaka, Valerie Race, Gert Matthijs, Tite Minga Mikobi, Koenraad Devriendt, Chris Van Geet, Prosper Tshilobo Lukusa
Publikováno v:
Hematology, Vol 28, Iss 1 (2023)
ABSTRACTBackground: Sickle Cell Anemia (SCA) is the most common genetic disease worldwide caused by a single mutation in the gene HBB. The disease severity is very variable and depends on many factors. We evaluated the clinical and biological profile
Externí odkaz:
https://doaj.org/article/34f2e67d7afd4d9691ea584959c2579a
Autor:
Paul Kabuyi Lumbala, Gloire Mbayabo, Mamy Nzita Ngole, Aimé Lumaka, Valerie Race, Gert Matthijs, Chris Van Geet, Prosper Tshilobo Lukusa, Koenraad Devriendt, Tite Minga Mikobi
Publikováno v:
PLoS ONE, Vol 17, Iss 12, p e0278478 (2022)
BackgroundSickle cell anemia (SCA) is a monogenic hemoglobinopathy associated with severe acute and chronic complications, with the highest incidence worldwide in Sub-Saharan Africa. The wide variability in clinical manifestations suggest that a unif
Externí odkaz:
https://doaj.org/article/fe73b06b50184c348dbc70de6f338622
Publikováno v:
PLoS ONE, Vol 17, Iss 10 (2022)
Introduction Malaria is associated with high morbidity during pregnancy. Homozygous sickle cell pregnant women are even more exposed during complicated malaria. The objective of the study was to evaluate the maternal and fetal morbidity of homozygous
Externí odkaz:
https://doaj.org/article/40e1bb4ec5c6479785872f5866881ccf
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 11, Iss 1 (2019)
FHb and alpha-thal are two genetic factors that modulate the clinical expression of sickle cell disease. Objective: to determine the beneficial role of FHb and alpha-thal on fetal and maternal morbidity during pregnancy in sickle cell patients.
Externí odkaz:
https://doaj.org/article/f207b6da62ea45c6a12f75a1432c1140
Autor:
Tite Minga Mikobi, Prosper Lukusa Tshilobo, Michel Ntetani Aloni, Georges Mvumbi Lelo, Pierre Zalagile Akilimali, Jean Jacques Muyembe-Tamfum, Valérie Race, Gert Matthijs, Jean Marie Mbuyi Mwamba
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0123568 (2015)
BackgroundSickle cell anemia is an inflammatory disease and is characterized by chronic hemolysis. We sought to evaluate the association of lactate dehydrogenase levels with specific clinical phenotypes and laboratory variables in patients with sickl
Externí odkaz:
https://doaj.org/article/3baf3175cee449f493cbded23cf7cf69
Autor:
Gloire Mbayabo, Paul Kabuyi Lumbala, Mamy Ngole, Aimé Lumaka, Valérie Race, Gert Matthijs, Tite Minga Mikobi, Koenraad Devriendt, Chris Van Geet, Prosper Tshilobo Lukusa
Sickle cell anemia is highly prevalent in Central Africa. The disease causes severe manifestations in children requiring treatment. Hydroxyurea is currently the most effective drug treatment. Therefore, we evaluated the use of HU in children living i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc40a17b059634fbc0559c09f29e822e
https://doi.org/10.22541/au.168321426.61233927/v1
https://doi.org/10.22541/au.168321426.61233927/v1
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 11, Iss 1 (2019)
Mediterranean Journal of Hematology and Infectious Diseases
Mediterranean Journal of Hematology and Infectious Diseases
FHb and alpha-thal are two genetic factors that modulate the clinical expression of sickle cell disease. Objective: to determine the beneficial role of FHb and alpha-thal on fetal and maternal morbidity during pregnancy in sickle cell patients. This
Autor:
Tite Minga, Mikobi, Prosper Tshilobo, Lukusa, Michel Ntetani, Aloni, Aimé, Lumaka, Pierre Zalagile, Akilimali, Koenraad, Devriendt, Gert, Matthijs, Jean-Marie, Mbuyi Muamba, Valerie, Race
Publikováno v:
Journal of clinical laboratory analysis. 32(1)
BACKGROUND: Information about the association with alpha thalassemia in sickle cell patients is unknown in the Democratic Republic of Congo. There is very little data on the alpha thalassemia in patients suffering from sickle cell anemia in Central A